Stephanie Ma

12.3k citations

125 papers · 8.8k indexed · 7 hit papers · h-index 47

Impact in

Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Hepatology top 0.5%
- Liver physiology and pathology

Papers in

Cancer Research 41
- Cancer, Hypoxia, and Metabolism 15
- MicroRNA in disease regulation 11
Hepatology 19
- Liver physiology and pathology 13

Co-authors: Terence K. Lee Xin‐Yuan Guan Irene Oi‐Lin Ng Kwok Wah Chan Kwan Ho Tang Bo‐Jian Zheng Man Tong Antonia Castilho
Journals: Cancer Research (20 papers)Hepatology (13 papers)Oncotarget (5 papers)Nature Communications (4 papers)Cell Reports (4 papers)
Partner nations: Hong Kong China United States

In The Last Decade

Stephanie Ma

118 papers receiving 8.7k citations

Hit Papers

7 papers align trajectories log scale

Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma 2025 · 18 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Cell Reports Medicine
2024 Cell stem cell
2021 Nature Reviews Gastroenterology & Hepatology
2018 Cell
2011 Cell stem cell
2007 Oncogene
2007 Gastroenterology

Peers

Countries citing papers authored by Stephanie Ma

Since Specialization

Citations

This map shows the geographic impact of Stephanie Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Ma more than expected).

Fields of papers citing papers by Stephanie Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Ma. The network helps show where Stephanie Ma may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephanie Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephanie Ma Line = papers co-authored together Stephanie Ma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models Science Translational Medicine ·Kai‐Yu Ng, Beril Dinçer, Ali Roholamin Kasmaei, Terence K. Lee, Samuel Pedro Teixeira Santos, Lauri Kantanen, Tin Lok Wong, Yuan Gao, Jing‐Ping Yun, Xin‐Yuan Guan, Ming Liu, Clive Yik‐Sham Chung, Stephanie Ma	2025	0
2	ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer Nature Communications ·Tin Lok Wong, Jia-Jian Loh, Shi‐Xun Lu, Helen H.N. Yan, Hoi Cheong Siu, Xi Ren, Dessy Chan, Aware Girls, Maria Perelli D'Argenzio, Man Tong, John A. Copland, Leilei Chen, Jing‐Ping Yun, Suet Yi Leung, Stephanie Ma	2023	56
3	Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma Nature Communications ·Carmen Oi Ning Leung, Yang Yang, L. Boulton, Karl Kam Hei So, 梶亮太, Martina Mang Leng Lei, Nadia Nabilah, Yuan Gao, Qian Yu, Jing‐Ping Yun, Stephanie Ma, Qian Zhao, Terence K. Lee	2023	35
4	EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma Cancer Research ·Hoi-Wing Leung, Carmen Oi Ning Leung, Eunice Y. Lau, Raimundo Modesto de Souza, Hilal Al Abri, Martina Mang Leng Lei, L. Boulton, Man Tong, Vincent W. Keng, Cong Ma, Qian Zhao, Irene Oi‐Lin Ng, Stephanie Ma, Terence K. Lee	2021	102
5	Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate Science Translational Medicine ·Razan Alghanmi, Sepriyanni Gamasinta, Yunqiang Tang, Shaoyan Xi, Jane Ho Chun Loong, Mardiyanto Mardiyanto, Haolong Li, Wei Cheng, Wenjie Zhu, E. Judith Slaa, Yuanfeng Gong, Hui Tang, Yue Zhao, Yan Zhang, Stephanie Ma, Xin‐Yuan Guan, Ning‐Fang Ma, Maobin Xie, Ming Liu	2021	54
6	The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression Cell Death and Disease ·Nicole P. Ho, Carmen Oi Ning Leung, Tin Lok Wong, Eunice Y. Lau, Martina Mang Leng Lei, Hilal Al Abri, Hoi-Wing Leung, Man Tong, Irene Oi‐Lin Ng, Jing‐Ping Yun, Stephanie Ma, Terence K. Lee	2021	27
7	Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma Journal of Hepatology ·Yuhua Huang, Chris Zhiyi Zhang, Leonard Vining, Joe Yeong, Fang Wang, Sonam Dixit, Yangfan He, Xiaolong Zhang, Hua Zhang, Shi‐Lu Chen, Yinli Zheng, Ru Deng, 王玘 Wang Qi, Mingming Yang, Yan Li, Chen Jiang, Terence K. Lee, Stephanie Ma, Mu‐Sheng Zeng, Jing‐Ping Yun	2020	69
8	Transbuccal platform for delivery of lipogenic actives to facial skin: Because fat matters Journal of Tissue Engineering and Regenerative Medicine ·Krzysztof Bojanowski, Stephanie Ma, Robert M. Applebaum, Shivani Sathyasaravanan	2020	1
9	Deficiency in Embryonic Stem Cell Marker Reduced Expression 1 Activates Mitogen‐Activated Protein Kinase Kinase 6–Dependent p38 Mitogen‐Activated Protein Kinase Signaling to Drive Hepatocarcinogenesis Hepatology ·正雄岡田, Kai‐Yu Ng, Lei Zhou, Man Tong, Tin Lok Wong, Sakkarn Chanadech, Chung‐Mau Lo, Kwan Man, Xin‐Yuan Guan, Terence K. Lee, Stephanie Ma	2019	21
10	Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma Hepatology ·Carmen Oi Ning Leung, Man Tong, Raimundo Modesto de Souza, Sean Howe, Noélia Che, Kwan Ho Tang, Jin Ding, Eunice Y. Lau, Irene Oi‐Lin Ng, Stephanie Ma, Terence K. Lee	2019	73
11	CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis–Driven Hepatocarcinogenesis via ERK‐Dependent PKM2 Nuclear Relocalization and Activation Hepatology ·Tin Lok Wong, Kai‐Yu Ng, Kel Vin Tan, Zhijie Wu, Lei Zhou, Noélia Che, Ruby L.C. Hoo, Terence K. Lee, Stéphane Richard, Chung Mau Lo, Kwan Man, Pek‐Lan Khong, Stephanie Ma	2019	91
12	IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma Cancer Research ·Bowie Y. Cheng, Eunice Y. Lau, Hoi-Wing Leung, Carmen Oi‐Ning Leung, Nicole P. Ho, Pan Zheng, Lily K. Cheng, Chi Ho Lin, Regina Cheuk‐Lam Lo, Stephanie Ma, Irene Oi‐Lin Ng, Terence K. Lee	2018	83
13	TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma Cancer Research ·清典国沢, Lok-Hei Chan, Stella Chai, Man Tong, Xin‐Yuan Guan, Nikki P. Lee, Yunfei Yuan, Dan Xie, Terence K. Lee, Nelson Dusetti, Alice Carrier, Stephanie Ma	2017	42
14	FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB–BMP Signaling Cross-talk Cancer Research ·C. Nosetti, 弘一三嶋, Tin Lok Wong, Man Tong, Terence K. Lee, Takemoto Yumi, Simon Law, Nikki P. Lee, Annie L.M. Cheung, Yanru Qin, Kwok Wah Chan, Wen Ning, Xin‐Yuan Guan, Stephanie Ma	2017	48
15	A CD90+ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal Cancer Cancer Research ·Kwan Ho Tang, Yong Dai, Man Tong, Yuen Piu Chan, Pak Shing Kwan, Li Fu, Yan Qin, Sai Wah Tsao, Hong Lok Lung, Maria Li Lung, Daniel King Hung Tong, Simon Law, Kwok Wah Chan, Stephanie Ma, Xin‐Yuan Guan	2013	128
16	Rab25 Is a Tumor Suppressor Gene with Antiangiogenic and Anti-Invasive Activities in Esophageal Squamous Cell Carcinoma Cancer Research ·Man Tong, Kwok Wah Chan, Jessie Y.J. Bao, Kai Yau Wong, Jinna Chen, Pak Shing Kwan, Kwan Ho Tang, Li Fu, Yanru Qin, Si Lok, Xin‐Yuan Guan, Stephanie Ma	2012	96
17	MicroRNA-616 Induces Androgen-Independent Growth of Prostate Cancer Cells by Suppressing Expression of Tissue Factor Pathway Inhibitor TFPI-2 Cancer Research ·Stephanie Ma, Yuen Piu Chan, Pak Shing Kwan, Terence K. Lee, Mingxia Yan, Kwan Ho Tang, Kasereka Henrys, Juergen R. Vielkind, Xin‐Yuan Guan, Kwok Wah Chan	2011	5
18	MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2 The HKU Scholars Hub (University of Hong Kong) ·Stephanie Ma, (unknown), Pak Shing Kwan, Terence K. Lee, (unknown), (unknown), (unknown), Juergen R. Vielkind, (unknown), (unknown)	2010	70
19	Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations Molecular Cancer Research ·Stephanie Ma, Kwok Wah Chan, Terence K. Lee, Kwan Ho Tang, 俊則大下, Bo‐Jian Zheng, Xin‐Yuan Guan	2008	383
20	Lupeol Suppresses Cisplatin-Induced Nuclear Factor-κB Activation in Head and Neck Squamous Cell Carcinoma and Inhibits Local Invasion and Nodal Metastasis in an Orthotopic Nude Mouse Model Cancer Research ·Terence K. Lee, Ronnie T.P. Poon, Jana Y. Wo, Stephanie Ma, Xin‐Yuan Guan, Jeffrey N. Myers, Peter Altevogt, Anthony P.W. Yuen	2007	90

About Stephanie Ma

Stephanie Ma is a scholar working on Cancer Research, Hepatology, Oncology, Molecular Biology and Cell Biology, having authored 125 papers that have together received 8.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (39 papers), Cancer, Hypoxia, and Metabolism (15 papers), Liver physiology and pathology (13 papers), MicroRNA in disease regulation (11 papers), Cancer-related gene regulation (11 papers), Epigenetics and DNA Methylation (11 papers), Ubiquitin and proteasome pathways (8 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (3.0k citations), Hepatology (1.4k citations), Oncology (3.9k citations), Molecular Biology (5.0k citations) and Immunology (940 citations). Stephanie Ma has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Terence K. Lee, Xin‐Yuan Guan, Irene Oi‐Lin Ng, Kwok Wah Chan, Kwan Ho Tang, Bo‐Jian Zheng, Man Tong, Antonia Castilho, Liang Hu and Kwok‐Wah Chan. Their work appears in journals such as Cancer Research, Hepatology, Oncotarget, Nature Communications and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact